information

  • Notice

    Year-End and New Year Holiday Notice

    ▼ View More

    We would like to inform you that our office will be closed for the New Year holidays during the following period:

    Holiday Period:December 30, 2025 (Tue) – January 4, 2026 (Sun)

    We will resume normal operations on January 5, 2026 (Mon).

    Inquiries received during the holiday period will be answered sequentially from January 5 onward.

    Thank you very much for your continued support throughout this year.

    We sincerely look forward to your continued patronage in 2026.

  • Notice

    Notice of D-MAH Medical Japan Website Renewal

    ▼ View More
    Thank you very much for your continued support and patronage.
    We are pleased to announce that our official website has been completely renewed.
    The new site has been redesigned to make it easier to navigate and to allow smoother access to the information you need. It provides clearer guidance on our medical device marketing authorization holder (MAH) support services, as well as our storage and manufacturing agency services, along with an improved explanation of the consultation process.
    We hope you will continue to favor us with your valued support in the future.

    D-MAH Medical Japan Co., Ltd.
  • Notice

    Implementation of Work-From-Home system

    ▼ View More
  • Notice

    Announcement of company anniversary holiday

    ▼ View More

    We are pleased to announce that our group company [EXPARTNER JAPAN Co., Ltd.] will celebrate its 24th anniversary on September 5, 2025, since its founding on September 5, 2001.
    We would like to express our sincere gratitude for your continued support and cooperation, which have made this milestone possible.
    We look forward to your continued patronage in the years to come.Please be informed that Friday, September 5, 2025, will be a company-wide holiday across all group entities in celebration of this anniversary.

  • Notice

    Introduction of our official social media account

    ▼ View More

    We are pleased to announce the launch of our official Facebook page. We invite you to visit and follow us for the latest updates and information.
       https://www.facebook.com/

    In addition, our group corporations, [EXPARTNER JAPAN Co., Ltd.] and [Health Technology Co-Creation Foundation], are also actively sharing updates through their respective social media platforms.
    ● EXPARTNER JAPAN Co., Ltd.
       https://www.facebook.com/

    ● Health Technology Co-Creation Foundation
      ・X:@htcf_2024
       https://x.com/htcf_2024
    ・ X(Regulatory Affairs School):@yakuji_school →「Regulatory Affairs School」Enrollment Now Open for October–December Courses!
       https://x.com/yakuji_school
      ・Facebook
       https://www.facebook.com/
      ・Instagram:@htcf_2024
       https://www.instagram.com/htcf_2024/
    ▼ You can also access our Instagram account via the QR code below

    We look forward to your continued support of our company, D-MAH MEDICAL JAPAN Co., Ltd., and our group companies.

service

Marketing Authorization Holder/MAH , Designated
Marketing Authorization Holder/DMAH Business

Our company holds a first-class marketing authorization holder license for medical
devices, and as a MAH and DMAH, we can handle all classes of medical devices.

DMAHDesignated Marketing
Authorization Holder

A foreign manufacturer who wishes to import and sell medical devices in Japan, with no established entity in the country, must appoint a company which hold the appropriate marketing authorization holder license.

日本市場参入を予定する外国企業が日本での製品認可 (ライセンス)を直接取得する制度 (外国特例承認/認証,DMAH制度) を活用することで、 外国企業は日本の販売業者 (ディーラー) との販売契約においてスムーズに交渉を進め、イニシアチブをとることができます。

MAHMarketing Authorization
Holder

The entity that bears final responsibility for medical devices on the market is called the Marketing Authorization Holder (MAH), and our company also provides this service on behalf of clients For domestic medical device companies, outsourcing the complex and burdensome compliance with the Pharmaceutical and Medical Device Act (PMDA) allows them to focus their management resources on the development and sales (marketing) departments, thereby improving productivity and achieving greater operational efficiency.